Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Silvia Ketterer"'
Autor:
Christoph Beglinger, Sibylle Oesch, Michel Casanova, Silvia Ketterer, Lukas Degen, Juergen Drewe, Stefanie Graf
Publikováno v:
Gastroenterology. 129:1430-1436
Studies in animals and humans suggest a role for peptide YY (PYY3-36) in regulating satiety. The physiologic role of PYY3-36, however, has not been investigated in detail.The present study was designed to examine PYY release in response to 2 meals di
Autor:
Finn Larsen, Silvia Ketterer, Annette Collet, Pius Hildebrand, Livid Rossi, Christoph Beglinger, Fuping Peng, Yolanda Serrano, Lukas Degen
Publikováno v:
Gastroenterology. 120:361-368
Background & Aims: This study was designed to characterize [D-F 5 Phe 6 D-Ala 11 ]Bn(6-13)OMe (BIM26226) as a gastrin-releasing peptide (GRP)-preferring bombesin receptor antagonist and to determine whether GRP physiologically regulates gastrointesti
Autor:
Juergen Drewe, Pius Hildebrand, Alexandra Krautheim, Christoph Beglinger, Jean-Pierre Gutzwiller, Silvia Ketterer
Publikováno v:
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 279:R189-R195
Cholecystokinin (CCK) interacts with neural signals to induce satiety in several species, but the mechanisms are unclear. We therefore tested the hypothesis that alimentary CCK (CCK-A) receptors mediate the interaction of CCK with an appetizer on foo
Autor:
Pius Hildebrand, Andre Fleury, Silvia Ketterer, Beat Burckhardt, Paul Hadvary, Christophe Petrig, Hans Lengsfeld, Christoph Beglinger
Publikováno v:
Gastroenterology. 114(1)
The hypothesis that cholecystokinin release requires adequate dietary fat digestion in the small intestine was investigated in 10 healthy volunteers, and the consequences of reduced fat hydrolysis on pancreaticobiliary secretions were assessed.Fat hy
Autor:
Sandro Mossi, F. Delco, Urs Bangerter, Pius Hildebrand, Silvia Ketterer, Christoph Beglinger, John W. Ensinck
Publikováno v:
The Journal of clinical endocrinology and metabolism. 72(5)
A cholecystokinin (CCK) receptor antagonist, loxiglumide, was used to investigate the potential regulating role of CCK in the entero-insular axis in humans. Ingestion of a mixed liquid meal stimulated plasma CCK, insulin, and pancreatic polypeptide (